|
|
![]() | ![]() | ![]() | ![]() |
This excerpt taken from the NVS 6-K filed Sep 21, 2005. Late-stage pipeline highlights Industry experts have consistently ranked Novartis as having one of the best pipelines, focusing on many compounds that have the potential to become a new standard of care and the first to market in their respective classes.
The priority development projects include:
Aclasta |
| |||||||